ANXA1 and cancer: In the perspective of tamoxifen resistance, ANXA1 and CALD1 may be involved in the activation of the NFκB pathway, which would promote cell survival by blocking intrinsic (mitochondrial-mediated) and extrinsic (death receptors-mediated) apoptotic signals and render cancer cells independent of estrogens.